Sulfasalazine
Back to searchMolecule Structure
Scientific Name
Sulfasalazine
Description of the Drug
Sulfasalazine is a salicylate used to treat Crohn’s disease, ulcerative colitis, and rheumatoid arthritis.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00795
http://www.drugbank.ca/drugs/DB00795
Brand Name(s)
Azulfidine, Azulfidine EN, Azulfidine en-tabs, Colizine, Salazopyrin, Salazopyrin e.c., Salazopyrin-en, Salazosulfapyridine, Salicylazosulfapyridine, S.a.s., S.a.s.-500, Sulfasalazine, Ucine
Company Owner(s)
Sun Pharmaceutical Industries Inc, Watson Laboratories Inc, Epic Pharma Inc, Superpharm Corp, Nuvo Phamaceuticals Inc, Solvay Pharmaceuticals, Pfizer Inc, Pharmacia And Upjohn Co, Chartwell Pharma Science Llc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Arachidonate 5-lipoxygenase | SINGLE PROTEIN | INHIBITOR | CHEMBL215 |
| Cyclooxygenase | PROTEIN FAMILY | INHIBITOR | CHEMBL2094253 |
Clinical Trial(s)
Unichem Links
| Atlas | sulfasalazine | ||
| SureChEMBL | SCHEMBL4515 | ||
| Human Metabolome Database | HMDB0014933 | ||
| DrugBank | DB00795 | ||
| PubChem: Thomson Pharma | 14830364 | ||
| Nikkaji | J2.073G | ||
| PDBe | SAS | ||
| BindingDB | 50103596 | ||
| EPA CompTox Dashboard | DTXSID0021256 | ||
| DrugCentral | 2525 | ||
| Brenda | 98241 | 20530 | 255214 |
| ChemicalBook | CB0181156 | ||
| Guide to Pharmacology | 4840 | ||
| rxnorm | SULFASALAZINE | AZULFIDINE | |
| PubChem: Drugs of the Future | 12012604 | ||
| KEGG Ligand | C07316 | ||
| ChEBI | 9334 | ||
| ZINC | ZINC000003831490 |
